Periodical (Journal)

  1. PSIthority
  2. Library
  3. Periodicals
ISSN  :   1861-0706 ( Print )   |   1861-0714 ( Online )   Active

Clinical Research in Cardiology Supplements

Aim & Scope
The journal Clinical Research in Cardiology Supplements offers a forum for specialized special publications (supplements) in the fields of clinical cardiology, angiology and cardiac and vascular surgery. It complements the two journals Clinical Research in Cardiology (original clinical papers) and Basic Research in Cardiology (original papers from basic cardiovascular research). The thematic booklets Clinical Research in Cardiology Supplements appear as required at irregular intervals and are the responsibility of a guest editor. [1]

Go to Website

Continuations
(  1974  -  1978  ) Zeitschrift für Kardiologie - Supplementum    (  2006  -  9999  ) Clinical Research in Cardiology Supplements
Supplement to
Active ( 2006  -  9999 ) Clinical Research in Cardiology

1861-0684 ( Print )  1861-0692 ( Online ) 
Springer ,  D. Steinkopff-Verlag ,  German Cardiac Society

246 2724
 
2019 - VOLUME 14, SUPPLEMENT 1
9 RESULTS in 11 msec
Lipoprotein(a).

KP Mellwig , A Vogt

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 1-4.

 
1 0
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region.

F Kronenberg

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 5-12.

  Review
12 0
Lipoprotein(a) and mortality-a high risk relationship.

R Klingel , A Heibges , C Fassbender

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 13-19.

 
3 0
Lipoprotein(a)-an interdisciplinary challenge.

U Julius , S Tselmin , U Schatz , ... , SR Bornstein

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 20-27.

 
1 0
Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism?

AH Nave , A von Eckardstein

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 28-32.

 
3 0
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.

VJJ Schettler , CL Neumann , C Peter , ... , Scientific Board of GLAR for the German Apheresis Working Group

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 33-38.

 
7 0
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results.

N Weiss , U Julius

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 39-44.

  Review
3 0
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors.

U Julius , S Tselmin , U Schatz , ... , SR Bornstein

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 45-50.

 
2 0
Lipoprotein(a)-antisense therapy.

A Vogt

Clinical Research in Cardiology Supplements , 2019 - VOLUME 14, SUPPLEMENT 1 , pp 51-56.

 
2 0